| Literature DB >> 33372624 |
Rawan Sharaf Eldein Elamein Hassan1, Sarah Osman Sayed Osman2, Mohamed Abdulmonem Salih Aabdeen3, Walid Elhaj Abdelrahim Mohamed2, Razan Sharaf Eldein Elamein Hassan4, Sagad Omer Obeid Mohamed2.
Abstract
BACKGROUND: Surgical site infections (SSIs) are common healthcare-associated infections and associated with prolonged hospital stays, additional financial burden, and significantly hamper the potential benefits of surgical interventions. Causes of SSIs are multi-factorials and patients undergoing gastrointestinal tract procedures carry a high risk of bacterial contamination. This study aimed to determine the prevalence, associated factors, and causing microorganisms of SSIs among patients undergoing gastrointestinal tract surgeries.Entities:
Keywords: SSI; Surgical site infections; gastrointestinal tract; risk factors
Year: 2020 PMID: 33372624 PMCID: PMC7722425 DOI: 10.1186/s13037-020-00272-4
Source DB: PubMed Journal: Patient Saf Surg ISSN: 1754-9493
Characteristics of the gastrointestinal surgical procedures done during the study period
| Variables | Frequency | Percent |
|---|---|---|
| Non-malignant | 52 | 65.0% |
| Malignant | 28 | 35.0% |
| Small bowel | 16 | 20.0% |
| Large bowel | 37 | 46.3% |
| Biliary | 25 | 31.3% |
| Pancreatic | 2 | 2.5% |
| Elective | 47 | 58.8% |
| Urgent | 33 | 41.3% |
| Gallbladder / common bile duct stones | 23 | 28.25% |
| Anal fistula | 20 | 25% |
| Large bowel tumor | 15 | 18.75% |
| Small bowel tumor | 10 | 12.5% |
| Gastric tumor | 6 | 7.5% |
| Gallbladder tumor | 3 | 3.75% |
| Pancreatic tumor | 3 | 3.75% |
| Laparoscopic cholecystectomy and stone extraction | 23 | 28.25% |
| Examination under anesthesia and fistulectomy | 20 | 25% |
| Bowel resection and anastomosis | 25 | 31.25% |
| Total gastrectomy | 6 | 7.5% |
| Radical cholecystectomy | 3 | 3.75% |
| Whipple operation | 3 | 3.75% |
| Clean | 2 | 2.5% |
| Clean-contaminated | 39 | 48.8% |
| Contaminated | 39 | 48.8% |
Risk factors associated with developing an SSI
| Variables | Total | Patients with SSI | ||
|---|---|---|---|---|
| Male | 43 (50.4%) | 13 (30.2%) | 0.555 | |
| Female | 37 (49.7%) | 9 (24.3%) | ||
| No | 54 (67.5%) | 12 (22.2%) | 0.128 | |
| Yes | 26 (32.5%) | 10 (38.5%) | ||
| Non malignant | 52 (65.0%) | 5 (9.60%) | > 0.001 | |
| Malignant | 28 (35.0%) | 17 (60.7%) | ||
| No | 41 (51.3%) | 9 (22.0%) | 0.254 | |
| Yes | 39 (48.8%) | 13 (33.3%) | ||
| No | 76 (95.0%) | 20 (26.3%) | 0.301 | |
| Yes | 4 (5.0%) | 2 (50.0%) | ||
| Small bowel | 16 (20.0%) | 8 (50.0%) | 0.074 | |
| Large bowel | 37 (46.3%) | 6 (16.2%) | ||
| Biliary | 25 (31.3%) | 7 (28.0%) | ||
| Pancreatic | 2 (2.5%) | 1 (50.0%) | ||
| Clean | 2 (2.5%) | 1 (50.0%) | 0.746 | |
| Clean-contaminated | 39 (48.8%) | 11 (28.2%) | ||
| Contaminated | 39 (48.8%) | 10 (25.6%) | ||
| No | 39 (48.8%) | 6 (15.4%) | 0.018 | |
| Yes | 41 (51.3%) | 16 (39.0%) | ||
| Less than 3 hours | 60 (70.6%) | 8 (14.3%) | > 0.001 | |
| More than 3 hours | 25 (29.4%) | 14 (58.3%) | ||
| No blood loss | 48 (60.0%) | 4 (8.30%) | > 0.001 | |
| Less than 500 ml | 18 (22.5%) | 9 (50.0%) | ||
| More than 500 ml | 7 (8.5%) | 3 (42.9%) | ||
| 2nd generation cephalosporin | 40 (50.0%) | 10 (25.0%) | 0.383 | |
| Metronidazol + 2nd generation cephalosporin | 35 (43.8%) | 11 (31.4%) | ||
| Metronidazol | 4 (5%) | 0 | ||
Features and types of microorganisms isolated from patients with SSI
| Variables | Total | |
|---|---|---|
| Superficial | 19 (82.6%) | |
| Deep | 3 (13%) | |
| Organ/space | 1 (4.3%) | |
| Day 3–4 | 8 (34.8%) | |
| Day 5–6 | 9 (39.1%) | |
| One week and more | 6 (26.1%) | |
| During admission | 19 (86.4%) | |
| After discharge | 3 (13.6%) | |
| 11 (47.8%) | ||
| 3 (13.0%) | ||
| 3 (13.0%) | ||
| 1 (4.30%) | ||
| 2 (8.70%) | ||
| 1 (4.30%) | ||
| 1 (4.30%) | ||